• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2020 Fiscal Year Final Research Report

Identification and functional analysis of a liver stromal cell-derived factor contributing to liver metastasis of colorectal cancer cells

Research Project

  • PDF
Project/Area Number 18K08693
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 55020:Digestive surgery-related
Research InstitutionMicrobial Chemistry Research Foundation

Principal Investigator

Tomokazu Ohishi  公益財団法人微生物化学研究会, 微生物化学研究所 沼津支所, 主任研究員 (50442546)

Project Period (FY) 2018-04-01 – 2021-03-31
Keywordsがんー間質相互作用
Outline of Final Research Achievements

In this study, we tried to identify a novel molecule, which is involved in the liver metastasis of colorectal cancer. We sought the possibility of a new therapeutic strategy targeting the molecule for the treatment of liver metastasis of colorectal cancer. 1)Plasminogen activator inhibitor-1 (PAI-1), a negative regulator of the fibrinolytic pathway is identified as a candidate of promoting factor of liver metastasis of colorectal cancer. 2) Treatment of PAI-1 inhibitor suppressed liver metastasis of colorectal cancer in a mouse model of liver metastasis of colorectal cancer. 3)Similarly, PAI-1 knockout mice suppressed liver metastasis of colorectal cancer compared with wild-type mice.
Taken together, PAI-1 promotes liver metastasis of colorectal cancer and inhibition of PAI-1 may suppress liver metastasis of colorectal cancer.

Free Research Field

基礎医学

Academic Significance and Societal Importance of the Research Achievements

大腸がんは国内罹患数が最も高いがんであり、早急な対応が急務である。大腸がんの転移は患者の予後不良に直結し、約7~8割を占める大腸がん肝転移の制御が重要である。現在、抗上皮成長因子受容体(EGFR)抗体薬が推奨されていないRAS変異型の大腸がん患者の存在が問題となっており、新たな治療戦略が求められてきた。我々が見出したPAI-1は大腸がん肝転移を促進する因子であることから、新たな治療標的として考えられる。その阻害剤や中和抗体は、抗EGFR抗体薬不応性のがんにも適用できると見込まれ、社会的意義は大きい。

URL: 

Published: 2022-01-27   Modified: 2023-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi